Treg engineers take aim at autoimmunity

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
jimmylegs
Volunteer Moderator
Posts: 12592
Joined: Sat Mar 11, 2006 3:00 pm

Treg engineers take aim at autoimmunity

Post by jimmylegs »

interesting:

Treg engineers take aim at autoimmunity (2021)
https://www.nature.com/articles/s41587-021-01115-y

"These souped-up cell therapies, if successful, should create a type of immunosuppressive bubble at the site of disease or transplant, inducing immune-dampening effects that are targeted to hot spots of inflammation.

The first recipients of these cells will include patients undergoing solid organ transplantation or hematopoietic stem cell transfer. But companies are also pursuing applications in type 1 diabetes (T1D), rheumatoid arthritis, multiple sclerosis, hemophilia and inflammatory bowel disease."
active members shape site content. if there is a problem, speak up!
use the report button to flag problematic post content to volunteer moderators' attention.
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Drug Pipeline”